Navigating the Challenges: The Impact of US-China Tensions on Biopharmaceutical Innovation
The escalating tensions between the US and China have permeated various sectors, including the biopharmaceutical industry, significantly impacting companies with footprints in both countries. This piece explores the implications of these tensions, focusing on the case of WuXi AppTec and the Biotechnology Innovation Organization’s (BIO) recent decision to sever ties. The BIO-WuXi Clash: What’s Going Read more
Exploring Clinical Trial Opportunities: Hungary’s 2024 Country Profile
Hungary is recognized for its advanced regulatory framework and state-of-the-art healthcare infrastructure, attracting pharmaceutical companies and clinical research organizations (CROs) to carry out their clinical trials there. The country’s clinical trial approval process is efficient and streamlined, in line with European Union standards, which substantially shortens the time needed to initiate new trials. As a Read more
World Kidney Day 2024
World Kidney Day is an annual global event on the second Thursday of March, focusing on raising awareness about kidney health and the impact of kidney diseases on individual well-being. Since its inception in 2006, it has evolved into a significant global health movement, spotlighting the substantial global health impact of kidney disease, a leading Read more
Clinical Research Focus. 26th Edition
Navigating the Future of Gene Therapy In January 2024, the FDA issued a guidance document, outlining critical considerations in the clinical development of CRISPR/CAS9 drug candidates. This guidance addresses the nuanced challenges associated with the development of human gene-edited (GE) products, placing particular emphasis on mitigating risks linked to both the gene therapy product itself Read more
